MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 25 filers reported holding MOLECULIN BIOTECH INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $111 | +117.6% | 129,600 | +7.8% | 0.00% | – |
Q3 2023 | $51 | -31.1% | 120,200 | -5.7% | 0.00% | – |
Q2 2023 | $74 | -18.7% | 127,400 | +34.7% | 0.00% | – |
Q1 2023 | $91 | +4.6% | 94,605 | +15.1% | 0.00% | – |
Q4 2022 | $87 | -99.9% | 82,200 | -2.7% | 0.00% | – |
Q3 2022 | $90,000 | -29.7% | 84,500 | -4.1% | 0.00% | – |
Q2 2022 | $128,000 | +19.6% | 88,100 | +47.1% | 0.00% | – |
Q1 2022 | $107,000 | +72.6% | 59,900 | +79.3% | 0.00% | – |
Q4 2021 | $62,000 | – | 33,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 1,040,529 | $3,122,000 | 1.00% |
OCCUDO QUANTITATIVE STRATEGIES LP | 23,484 | $70,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 27,400 | $82,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 175 | $1,000 | 0.00% |
NORTHERN TRUST CORP | 50,731 | $152,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 1,403 | $4,000 | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 20,198 | $61,000 | 0.00% |
OSAIC HOLDINGS, INC. | 801 | $2,000 | 0.00% |
Rockefeller Capital Management L.P. | 2,777 | $8,000 | 0.00% |